Disclaimer: This is an early beta prototype. If you find any error, with data or functionality, please let us know via this page.
Sample size
Registration date period
  1. Circulating Tumor Cells and Tumor DNA in HCC and NET

    Registration date:
    Status:
    Ongoing
    Recruitment status:
    Recruiting

    Background Treatment and control of cancer is associated with high costs, to patients in the form of side effects and discomfort during investigations, to society in the form of expensive...

    Conditions:
    • Carcinoma, hepatocellular
    • Neuroendocrine Tumors
    Interventions:
    • Lanreotide
    • EVEROLIMUS
    • SORAFENIB
    • Radiofrequency ablation (RFA) or surgery
  2. ALK/ROS1/MET Mutations on Plasma ctDNA in Patients With NSCLC

    Registration date:
    Status:
    Ongoing
    Recruitment status:
    Not recruiting

    The study aims to explore the prevalence of ALK/ROS1/MET mutations assessed with ctDNA samples in EGFR-wildtype NSCLC

    Conditions:
    • EGFR Wildtype
    • Non-small Cell Lung Cancer Metastatic
    • Non-small cell lung cancer, stage III
    • Adenocarcinoma of Lung
    Interventions:
    • ctDNA analysis
  3. Circulating Cell-free Tumor DNA(ctDNA) in Pancreatic Cancer

    Registration date:
    Status:
    Ongoing
    Recruitment status:
    Recruiting

    The aim of the study is to evaluate whether peripheral circulating cell-free tumor DNA(ctDNA) can help early screening of pancreatic cancer recurrence or not. And we are also planning to...

    Conditions:
    • Pancreatic cancer
    Interventions:
  4. Circulating Tumoral DNA in Choroidal Melanoma (ctDNA MU)

    Registration date:
    Status:
    Ongoing
    Recruitment status:
    Not recruiting

    Quantification and follow-up during 3 years of circulating tumoral DNA in patients with choroidal melanoma

    Conditions:
    • Choroidal Melanoma
    Interventions:
    • Blood sampling
  5. Use of ctDNA for Monitoring of Stage III Colorectal Cancer

    Registration date:
    Status:
    Ongoing
    Recruitment status:
    Not recruiting

    This observational study will evaluate circulating tumor DNA (ctDNA) as a prognostic marker and as a monitor of disease recurrence in stage III colorectal cancer (CRC).

    Conditions:
    • Stage III colorectal cancer
    Interventions:
  6. Identifying Genomic Mutations of Multiple Primary Lung Cancers by Circulating Tumor DNA

    Registration date:
    Status:
    Ongoing
    Recruitment status:
    Not recruiting

    Targeted next generation sequencing (NGS) provides a promising method for diagnostic purposes by enabling the simultaneous detection of multiple gene mutations. This study is to evaluate...

    Conditions:
    • Thoracic Neoplasms
    • Carcinoma
    • non-small cell lung cancer
    Interventions:
  7. The Role of ctDNA and PBMC in Treatment of Biliary Tract Cancer

    Registration date:
    Status:
    Ongoing
    Recruitment status:
    Recruiting

    Our study aims to evaluate the role of ct-DNA and PBMC as biomarkers in the treatment of biliary tract cancer.

    Conditions:
    • Biliary Tract Neoplasms
    Interventions:
    • surgery or biopsy